Glycotope is Tubulis's #1 competitor. Glycotope's headquarters is in Berlin, Berlin, and was founded in 2000. Like Tubulis, Glycotope also works within the Biotechnology sector. Glycotope generates ∞% of Tubulis's revenue.
NBE-Therapeutics is one of Tubulis's top rivals. NBE-Therapeutics was founded in Basel, Basel-Country} in 2012. NBE-Therapeutics competes in the Health Care Services industry. Compared to Tubulis, NBE-Therapeutics generates $5M more revenue.
No recent acquisitions found related to Tubulis
Since Tubulis was founded in 2016, it has participated in 2 rounds of funding. In total Tubulis has raised $12.2M. Tubulis' last funding round was on Jul 2020 for a total of $12.2M
No recent investments found related to Tubulis